These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 8197034)
1. Symptomatology, pulmonary function and response, and T lymphocyte beta 2-receptors during smoking cessation in patients with chronic obstructive pulmonary disease. Leader WG; Wolf KM; Cooper TM; Chandler MH Pharmacotherapy; 1994; 14(2):162-72. PubMed ID: 8197034 [TBL] [Abstract][Full Text] [Related]
2. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors. Chandler MH; Schuldheisz S; Phillips BA; Muse KN Pharmacotherapy; 1997; 17(2):224-34. PubMed ID: 9085312 [TBL] [Abstract][Full Text] [Related]
3. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247 [TBL] [Abstract][Full Text] [Related]
4. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Lerman C; Tyndale R; Patterson F; Wileyto EP; Shields PG; Pinto A; Benowitz N Clin Pharmacol Ther; 2006 Jun; 79(6):600-8. PubMed ID: 16765148 [TBL] [Abstract][Full Text] [Related]
5. Terbutaline serum concentrations related to different lung function parameters and beta-receptor function. van den Berg W; Leferink JG; Tabingh Suermondt W; Kreukniet J; Maes RA; Serra R; Bruynzeel PL Int J Clin Pharmacol Ther Toxicol; 1983 Jan; 21(1):24-30. PubMed ID: 6299982 [TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro beta 2-adrenergic receptor responsiveness in young and elderly asthmatics. Hamelin BA; Blouin RA; Wolf KM; Clifton GD; Chandler MH Pharmacotherapy; 1992; 12(5):376-82. PubMed ID: 1331993 [TBL] [Abstract][Full Text] [Related]
7. Smoking cessation advice for patients with chronic periodontitis. Nasry HA; Preshaw PM; Stacey F; Heasman L; Swan M; Heasman PA Br Dent J; 2006 Mar; 200(5):272-5; discussion 265. PubMed ID: 16528334 [TBL] [Abstract][Full Text] [Related]
8. [Success of smoking cessation in patients with chronic obstructive pulmonary disease]. Aytemur Solak Z; Başoğlu OK; Erdinç E Tuberk Toraks; 2006; 54(1):43-50. PubMed ID: 16615017 [TBL] [Abstract][Full Text] [Related]
10. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial. Shiffman S Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988 [TBL] [Abstract][Full Text] [Related]
11. The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: a pre-post-test study. Monninkhof E; van der Valk P; van der Palen J; Mulder H; Pieterse M; van Herwaarden C; Zielhuis G Patient Educ Couns; 2004 Mar; 52(3):231-6. PubMed ID: 14998591 [TBL] [Abstract][Full Text] [Related]
12. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan. Islam SS; Schottenfeld D Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Wagena EJ; Knipschild PG; Huibers MJ; Wouters EF; van Schayck CP Arch Intern Med; 2005 Oct; 165(19):2286-92. PubMed ID: 16246996 [TBL] [Abstract][Full Text] [Related]
14. [The changes in beta-adrenergic receptors and cyclic AMP levels of lymphocytes in patients with COPD]. Gao DW Zhonghua Jie He He Hu Xi Za Zhi; 1989 Feb; 12(1):27-9, 62. PubMed ID: 2567638 [TBL] [Abstract][Full Text] [Related]
15. Effects of 24-hr nicotine replacement on sleep and daytime activity during smoking cessation. Wolter TD; Hauri PJ; Schroeder DR; Wisbey JA; Croghan IT; Offord KP; Dale LC; Hurt RD Prev Med; 1996; 25(5):601-10. PubMed ID: 8888329 [TBL] [Abstract][Full Text] [Related]
16. The beta-adrenergic system of non-allergic patients with chronic airflow obstruction and early morning dyspnoea. Meurs H; Postma DS; Koëter GH; Keyzer JJ; Timmermans A; Kauffman HF; de Vries K Ann Allergy; 1987 Dec; 59(6):417-21. PubMed ID: 2827542 [TBL] [Abstract][Full Text] [Related]
18. Influence of smoking cessation on airway T lymphocyte subsets in COPD. Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224 [TBL] [Abstract][Full Text] [Related]
19. Does additional support by nurses enhance the effect of a brief smoking cessation intervention in people with moderate to severe chronic obstructive pulmonary disease? A randomised controlled trial. Wilson JS; Fitzsimons D; Bradbury I; Stuart Elborn J Int J Nurs Stud; 2008 Apr; 45(4):508-17. PubMed ID: 17184783 [TBL] [Abstract][Full Text] [Related]
20. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Ferguson SG; Gitchell JG; Shiffman S; Sembower MA Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]